Efficacy and safety of tripterygium glycosides for active moderate to severe Graves’ ophthalmopathy: a randomised, observer-masked, single-centre trial

BACKGROUND: Tripterygium glycosides (TG) has been used to treat a spectrum of inflammatory and autoimmune diseases. Our preliminary studies have shown that TG is effective in the treatment of active Graves’ ophthalmopathy (GO). OBJECTIVE: We aimed to compare the efficacy and tolerability of TG with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Xiaozhen, Zhao, Heng, Liu, Jun, Lu, Bin, Shao, Jiaqing, Wang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849376/
https://www.ncbi.nlm.nih.gov/pubmed/33539318
http://dx.doi.org/10.1530/EJE-20-0857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849376/
https://www.ncbi.nlm.nih.gov/pubmed/33539318
http://dx.doi.org/10.1530/EJE-20-0857

Ejemplares similares